| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 94.90M | 81.00M | 86.98M | 73.33M | 112.80M | 52.33M |
| Gross Profit | 59.02M | 44.02M | 54.53M | 39.70M | 68.19M | 19.35M |
| EBITDA | 62.41M | 48.38M | 53.84M | 31.94M | 63.89M | 8.73M |
| Net Income | 33.46M | 22.22M | 27.50M | 10.76M | 38.22M | -26.74M |
Balance Sheet | ||||||
| Total Assets | 358.27M | 333.57M | 318.28M | 326.40M | 349.76M | 334.79M |
| Cash, Cash Equivalents and Short-Term Investments | 94.17M | 80.05M | 63.04M | 74.97M | 98.32M | 88.47M |
| Total Debt | 1.24M | 1.45M | 1.75M | 14.64M | 4.16M | 7.64M |
| Total Liabilities | 59.83M | 59.47M | 63.91M | 93.33M | 95.88M | 103.19M |
| Stockholders Equity | 298.44M | 274.10M | 254.37M | 233.07M | 253.88M | 231.61M |
Cash Flow | ||||||
| Free Cash Flow | 19.70M | 20.06M | 8.42M | 1.07M | 22.55M | 4.50M |
| Operating Cash Flow | 30.46M | 30.82M | 12.54M | 1.16M | 30.14M | 9.23M |
| Investing Cash Flow | -10.71M | -10.74M | -3.79M | -13.74M | 10.19M | -4.72M |
| Financing Cash Flow | -2.82M | -2.10M | -19.68M | -5.84M | -33.37M | -9.41M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | HK$2.84B | 10.92 | 11.86% | ― | 10.53% | 26.74% | |
61 Neutral | HK$1.79B | 9.63 | 7.57% | 5.71% | 0.59% | ― | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
56 Neutral | HK$27.78B | 46.50 | 3.30% | ― | 40.31% | 212.50% | |
48 Neutral | HK$592.37M | -16.13 | -14.60% | ― | -44.93% | 30.34% | |
46 Neutral | HK$1.06B | ― | ― | ― | ― | ― | |
45 Neutral | HK$179.18M | -6.10 | 24.24% | ― | -7.90% | 93.34% |
IMAX China Holding has amended its existing services agreements between IMAX Corporation and its subsidiaries IMAX Shanghai Multimedia and IMAX Hong Kong, effective 1 December 2025, to update and broaden the scope of services and the range of activities subject to variable service fees, while keeping other key terms unchanged. The board has raised the annual caps for aggregate fees payable under these services agreements to HK$20.8 million for each of 2025 and 2026, and set new annual caps of HK$4 million per year for 2026–2028 under the IMAX Shanghai Services Agreement; as these continuing connected transactions with controlling shareholder IMAX Corporation fall within the 0.1%–5% threshold of the Hong Kong Listing Rules, they are exempt from independent shareholders’ approval but remain subject to reporting and announcement requirements, with conflicted directors abstaining from the vote.
The most recent analyst rating on (HK:1970) stock is a Hold with a HK$8.50 price target. To see the full list of analyst forecasts on IMAX China Holding stock, see the HK:1970 Stock Forecast page.
IMAX China Holding, Inc. has formalized the terms of reference for its Nomination Committee, a board committee responsible for overseeing the selection and appointment of directors. The document sets out that the committee must comprise at least three directors, with a majority being independent non-executive directors, and requires a quorum of two members including at least one independent non-executive director. The chairman of the Nomination Committee will be appointed by the board and must be either an independent non-executive director or the board chairman, and the committee must include at least one director of a different gender, aligning the company’s governance structure with Hong Kong listing and corporate governance requirements and reinforcing its commitment to board independence and diversity.
The most recent analyst rating on (HK:1970) stock is a Hold with a HK$8.50 price target. To see the full list of analyst forecasts on IMAX China Holding stock, see the HK:1970 Stock Forecast page.
IMAX China Holding, Inc. announced that its controlling shareholder, IMAX Corporation, released its third quarter 2025 financial results and quarterly report. This announcement is significant for stakeholders as it provides insights into the financial health and operational statistics of the parent company, which could impact IMAX China’s market positioning and investor relations. The financial data, prepared under U.S. GAAP, is not directly comparable to IMAX China’s reports, which adhere to IFRS, highlighting potential differences in financial performance metrics.
The most recent analyst rating on (HK:1970) stock is a Hold with a HK$9.00 price target. To see the full list of analyst forecasts on IMAX China Holding stock, see the HK:1970 Stock Forecast page.